Latest Safety News

Core Lithium has greenlit the restart of its Finniss Lithium Project with a fully funded A$290 million package, initiating mining activities and targeting spodumene concentrate production by September 2026.

Emerald Resources NL posted a record March quarter pre-tax operating cash flow of A$143 million from its Okvau Gold Mine, maintaining full-year gold production guidance while progressing development and exploration at its Dingo Range and Memot projects.

Sandfire Resources faced a tragic fatality at its Magdalena mine and production challenges in Q3 FY26, yet sustained financial strength and advanced its Kalkaroo project, keeping full-year copper equivalent guidance intact.

Coronado Global Resources (ASX: CRN) will hold its 2026 Annual General Meeting virtually on June 4, 2026, following a challenging 2025 marked by a $432 million net loss amid weak metallurgical coal prices and logistical constraints. The company reported operational improvements and liquidity support from Stanwell, while navigating leadership changes and ongoing risks.

Black Cat Syndicate posted solid operating cash flow of A$61 million in the March quarter, driven by the ramp-up at Kal East and a strategic $20 million expansion of the Lakewood processing facility. The company also reported a 95% increase in antimony resources at Mt Clement, signaling growth potential beyond gold.

West African Resources (ASX:WAF) closed Q1 2026 with a record A$847 million cash balance, underpinned by robust gold production of 107,728 ounces at an AISC of US$1,921/oz. Meanwhile, Burkina Faso's government formalised a 25% acquisition in the Kiaka project for A$175 million, marking a significant shift in ownership.

Elevra Lithium delivered a strong March 2026 quarter with record revenues, operational improvements at North American Lithium, and progress on multiple growth fronts, supported by a robust cash position.

ikeGPS Group delivered a strong FY26 with platform subscription revenue up 33% to NZ$19.2 million and positive underlying EBITDA in March, supported by AI-driven pricing and expanding US utility adoption.

Racura Oncology has detailed how its lead drug candidate, (E,E)-bisantrene, silences the cancer-driving MYC gene by stabilising G-quadruplex DNA structures, providing critical preclinical validation ahead of ongoing clinical trials.

Alterity Therapeutics has unveiled fresh Phase 2 data revealing ATH434’s ability to slow functional decline in Multiple System Atrophy patients, measured by the novel MuSyCA scale. This reinforces the drug’s disease-modifying potential ahead of pivotal Phase 3 trials.

Hillgrove Resources posted a record 3,120 tonnes of copper production in Q1 2026, driving a 22% jump in cash to $25.2 million. The company’s exploration at Emily Star and Nugent underpins ambitions to surpass 2 million tonnes annual throughput.

Elsight Limited has reported a staggering 12-fold revenue increase in Q1 2026 to US$11.6 million, driven by strong U.S. defence contracts and early commercial traction. The company also soft-launched a GNSS-denied positioning product, marking a strategic shift toward a broader uncrewed systems platform.